Antibody News and Research

RSS

An antibody is a blood protein that is produced in response to and counteracts an antigen. Antibodies are produced in response to disease and help the body fight against the particular disease. In this way, antibodies help the body develop an immunity to disease.

Austrian researchers in a world first have successfully engineered an allergy vaccine

Austrian researchers in a world first have successfully engineered an allergy vaccine using a genetically modified version of the birch pollen allergen.

9 Aug 2004

Zyomyx issued five new biotech patents

Zyomyx a privately held biotechnology company, has announced that the United States Patent and Trademark Office issued five new patents to the Company. With these additions, Zyomyx has further strengthened its proprietary position in the area of protein biochip technology development and commercialization.

6 Aug 2004

Mothers who catch a flu during pregnancy may increase the risk of their child developing schizophrenia

Schizophrenia is a chronic, severe, and disabling brain disease. Approximately 1 percent of the population develops schizophrenia during their lifetime — more than 2 million Americans suffer from the illness in a given year.

3 Aug 2004

Renal research boost for the University of Birmingham

The Medical School at the University of Birmingham is amongst four UK winners of the prestigious Genzyme Renal Innovations Programme (GRIP).

2 Aug 2004

New glycan arrays discover autoimmunogenic activities of SARS-CoV

Researchers in New York City and Guangzhou, China applied the rapidly-developing carbohydrate microarray technology to study an inactivated SARS-coronavirus (SARS-CoV) vaccine and discovered autoimmunogenic activity of this newly identified human viral pathogen.

2 Aug 2004

Corus Pharma selected as a biotech company to watch

Corus Pharma announced yesterday that it has been selected as a member of FierceBiotech's annual "The Fierce 15." FierceBiotech Editor-in-Chief John D. Carroll observed "We applaud Corus' ongoing commitment to increasing the quality of life for people living with cystic fibrosis."

29 Jul 2004

Women with a history of cancer in their family are better off having MRI scans instead of mammograms

New research by Mieke Kriege at the Department of Medical Oncology, Rotterdam Family Cancer Clinic suggests that women with a history of cancer in their family are better off having MRI scans instead of mammogram's.

28 Jul 2004

Innovative treatment for cancer patients who have previously undergone chemotherapy, surgery or radiotherapy

At the inauguration of Hadassah's new day care center of the Sidney Weisner Department of Bone Marrow Transplantation and Cancer Immunotherapy today, Prof. Shimon Slavin, head of the department, described an innovative treatment for cancer patients who have previously undergone chemotherapy, surgery and/ or radiotherapy.

26 Jul 2004

European scientists expect to begin human trials using pharmaceuticals grown in GM plants

The European Union has awarded €12 million to a network of scientists in 11 European countries and South Africa and the aim is to use plants to produce vaccines and treatments against major diseases including AIDS, rabies, diabetes and TB.

23 Jul 2004

Autism antibodies are not genetically determined, as parents do not exhibit them

Autism produces a widespread range of antibodies that act against brain tissue and one protein in particular seems to be the major target of these antibodies claim a group of scientists in the July issue of the Journal of Neuroimmunology.

23 Jul 2004

Several key findings from clinical trial of an investigational Alzheimer's disease treatment

Elan Corporation and Wyeth Pharmaceuticals have announced several key findings from their Phase IIa clinical trial of an investigational Alzheimer's disease (AD) treatment, AN-1792, which were presented in Philadelphia at the 9th International Conference on Alzheimer's Disease and Related Disorders.

22 Jul 2004

Erbitux (cetuximab) combined with irinotecan offers another option for patients who have colorectal cancer

Erbitux (cetuximab), offers another option for patients who have colorectal cancer that resists standard chemotherapy treatment, according to an article written by two Mayo Clinic cancer researchers published in the current edition of the New England Journal of Medicine.

21 Jul 2004

Computer modeling method for mapping the evolution of the influenza virus

A University of California scientist working at Los Alamos National Laboratory with collaborators from the University of Cambridge (England) and the World Health Organization National Influenza Center at Erasmus Medical Center, (Rotterdam, Netherlands) have developed a computer modeling method for mapping the evolution of the influenza virus.

21 Jul 2004

Environmental Proteomics to design antibodies for the global market

The business fills a niche in the world market by manufacturing custom-made tools (antibodies) used in the study of proteins. Antibodies for use in typical laboratory subjects such as mammals are easily obtained, but it is very difficult to find these tools for use with other organisms, such as fish, plants, and algae. Recognizing the need for these products through his own research at Mount A over the last six years, Campbell appreciated the innovative applications of his findings.

21 Jul 2004

A new vaccine that may delay cancer recurrence

A therapeutic cancer vaccine being co-developed by the Ludwig Institute for Cancer Research and the Australian biotech company CSL Limited successfully induced a comprehensive immune response in patients and appeared to delay cancer recurrence

21 Jul 2004

Russian scientists incorporate HIV antigen into a tomato

Russian scientists are currently creating a pleasant and harmless vaccine, and edible one at that. So far, they managed to incorporate the protein gene – HIV antigen in tomatoes. The research is supported by International Science and Technology Center.

19 Jul 2004

West Nile Virus in South Dakota

West Nile virus (WNV) was first detected in the Western Hemisphere in 1999 in New York City. The virus spread west across the continent, reaching South Dakota in 2002.

19 Jul 2004

Results from clinical trial of TA-NIC, therapeutic vaccine for the treatment of nicotine addiction

Xenova Group has announced initial results from the second clinical trial of TA-NIC, the Company's therapeutic vaccine being developed for the treatment of nicotine addiction.

17 Jul 2004

Effective treatment for soft tissue sarcoma (rhabdomyosarcoma)

Rhabdomyosarcoma is a highly malignant aggressive form of soft tissue cancer in children, the causes of which are currently unknown. Although the fibrous growths can be found all over the body they commonly develop around the head, neck, bladder and testes in young boys.

15 Jul 2004

Research team developing new defenses against plague and smallpox

Using a federal biodefense grant, a Wake Forest University Baptist Medical Center team will try to develop new approaches to immunizing people against the plague and smallpox, two of the most feared potential agents of bio-terrorism.

15 Jul 2004

Antibody News and Research

Further Reading

Austrian researchers in a world first have successfully engineered an allergy vaccine

Zyomyx issued five new biotech patents

Mothers who catch a flu during pregnancy may increase the risk of their child developing schizophrenia

Renal research boost for the University of Birmingham

New glycan arrays discover autoimmunogenic activities of SARS-CoV

Corus Pharma selected as a biotech company to watch

Women with a history of cancer in their family are better off having MRI scans instead of mammograms

Innovative treatment for cancer patients who have previously undergone chemotherapy, surgery or radiotherapy

European scientists expect to begin human trials using pharmaceuticals grown in GM plants

Autism antibodies are not genetically determined, as parents do not exhibit them

Several key findings from clinical trial of an investigational Alzheimer's disease treatment

Erbitux (cetuximab) combined with irinotecan offers another option for patients who have colorectal cancer

Computer modeling method for mapping the evolution of the influenza virus

Environmental Proteomics to design antibodies for the global market

A new vaccine that may delay cancer recurrence

Russian scientists incorporate HIV antigen into a tomato

West Nile Virus in South Dakota

Results from clinical trial of TA-NIC, therapeutic vaccine for the treatment of nicotine addiction

Effective treatment for soft tissue sarcoma (rhabdomyosarcoma)

Research team developing new defenses against plague and smallpox

Immunology eBook

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest Life Science News